Catalyst Wire Dossier Catalyst Wire Dossier

Gan & Lee Insulin Glargine

insulin glargine · Gan & Lee Pharmaceuticals, USA
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Gan & Lee Insulin Glargine, covering 2022-03-23 to 2022-03-23. Get the full timeline:

Most recent: Clinical Trial Update: Gan & Lee Insulin Glargine Target Type (2) Evaluating Research [Phase 3]

See pricing